MTND5P2

Across TCGA pan-cancer cohorts, MTND5P2 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated MTND5P2 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MTND5P2 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MTND5P2 expression acts as an unfavorable survival marker, although some lineages such as STAD and UCEC show a favorable association.

STAD, UCS, and READ are the cancer types where MTND5P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	II,III,IV	0.684	0.430	.010	38	view →
UCS	DFS	Tertile	II,III,IV	0.118	0.431	.006	36	view →
READ	DFS	Tertile	III,IV	0.389	0.827	.001	36	view →
UCEC	DFS	Median	IV	0.677	0.219	.002	32	view →
OV	DFS	Tertile	IV	0.283	0.522	.009	20	view →
LGG	DFS	Tertile	All	0.740	0.849	.004	18	view →
LAML	DFS	Quartile	All	0.538	0.228	.007	16	view →
KIRC	OS	Median	All	0.488	0.693	<.001	14	view →
CESC	OS	Tertile	IV	0.877	0.396	.027	12	view →
THCA	OS	Tertile	IV	0.892	1.000	.021	10	view →
BRCA	DFS	Quartile	II,III,IV	0.836	0.896	.021	10	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

MTND5P2–STAD (OS)

Open the STAD breakdown →